Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06694558
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
Sponsor: The Cleveland Clinic
View on ClinicalTrials.gov
Summary
This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by glucagon-like peptide (GLP-1) agonist treatment ex vivo.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2025-03-01
Completion Date
2026-07-01
Last Updated
2025-06-11
Healthy Volunteers
No
Locations (1)
Cleveland Clinic
Cleveland, Ohio, United States